Re: Do Mixed Histological Features Affect Survival Benefit from Neoadjuvant Platinum-Based Combination Chemotherapy in Patients with Locally Advanced Bladder Cancer? A Secondary Analysis of Southwest Oncology Group-Directed Intergroup Study (S8710)

2012 ◽  
Vol 188 (1) ◽  
pp. 72-72
Author(s):  
David P. Wood
Keyword(s):  
Bladder Cancer ◽  
Combination Chemotherapy ◽  
Survival Benefit ◽  
Locally Advanced ◽  
Secondary Analysis ◽  
Oncology Group ◽  
Southwest Oncology Group ◽  
Histological Features ◽  
Advanced Bladder Cancer

Survival Benefit Persists With Delayed Initiation of Adjuvant Chemotherapy Following Radical Cystectomy for Locally Advanced Bladder Cancer

Urology ◽  
2019 ◽  
Vol 132 ◽  
pp. 143-149 ◽  
Author(s):  
Christopher J. Corbett ◽  
Leilei Xia ◽  
Ronac Mamtani ◽  
Stanley Bruce Malkowicz ◽  
Thomas J. Guzzo
Keyword(s):  
Bladder Cancer ◽  
Adjuvant Chemotherapy ◽  
Radical Cystectomy ◽  
Survival Benefit ◽  
Locally Advanced ◽  
Advanced Bladder Cancer ◽  
Delayed Initiation

Combination Chemotherapy with Intra-Arterial Cisplatin and Doxorubicin Plus Intravenous Methotrexate and Vincristine for Locally Advanced Bladder Cancer

1995 ◽  
Vol 154 (5) ◽  
pp. 1704-1709 ◽  
Author(s):  
Seiji Naito ◽  
Toshiro Kuroiwa ◽  
Toyofumi Ueda ◽  
Kanehiro Hasuo ◽  
Kouji Masuda ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Combination Chemotherapy ◽  
Locally Advanced ◽  
Advanced Bladder Cancer

Combination Cisplatin and Dichloromethotrexate in Patients with Advanced Bladder Cancer. Phase 2. A Southwest Oncology Group Study

1992 ◽  
Vol 148 (1) ◽  
pp. 52-54 ◽  
Author(s):  
Frederick J. Meyers ◽  
Brent Blumenstein ◽  
E. David Crawford ◽  
Harry E. Hynes ◽  
James E. Montie ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Phase 2 ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Southwest Oncology Group ◽  
Advanced Bladder Cancer ◽  
Southwest Oncology Group Study
Sign in / Sign up

Export Citation Format

Share Document